WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹5.13 Cr | ₹4.95 Cr | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹5.13 Cr |
| Mar2025 | ₹4.95 Cr |
| Mar2024 | ₹3.95 Cr |
| Mar2023 | ₹3.44 Cr |
| Mar2022 | ₹0.21 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.13 Cr | 3.63 | |
| Mar2025 | ₹4.95 Cr | 25.46 | |
| Mar2024 | ₹3.95 Cr | 14.84 | |
| Mar2023 | ₹3.44 Cr | 1,513.62 | |
| Mar2022 | ₹0.21 Cr | - | |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,816.3 Cr | 5% | 8% | -4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 5% |
8% |
-4.2% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses